David J. Brailer - Mar 1, 2024 Form 4 Insider Report for Cigna Group (CI)

Role
EVP & Chief Health Officer
Signature
Matthew Arnold, attorney-in-fact
Stock symbol
CI
Transactions as of
Mar 1, 2024
Transactions value $
-$503,707
Form type
4
Date filed
3/5/2024, 05:43 PM
Previous filing
Mar 1, 2024
Next filing
Sep 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Award $0 +2.78K +34.48% $0.00 10.8K Mar 1, 2024 Direct F1
transaction CI Common Stock, $.01 Par Value Tax liability -$137K -412 -3.8% $333.36 10.4K Mar 1, 2024 Direct F2
transaction CI Common Stock, $.01 Par Value Tax liability -$366K -1.1K -10.54% $333.36 9.33K Mar 1, 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2021-2023 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
F2 Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
F3 Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.